Wat betsjut "Dúdlik"?
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Hûn Primêre siliêre dyskinesia yn Alaskan Malamute (PCD-AM)
The DNA test for Primary Ciliary Dyskinesia (PCD) in Alaskan Malamutes is essential for responsible breeders and dog owners. PCD is a genetic disorder that affects the cilia function, leading to respiratory issues and reduced quality of life in affected dogs. Early detection through this DNA test helps identify carriers and affected Alaskan Malamutes, enabling informed breeding decisions to reduce the incidence of PCD. By using the PCD DNA test, breeders can promote healthier bloodlines and improve overall breed health. This test is simple, accurate, and vital for preventing the spread of this hereditary condition. Ensure your Alaskan Malamute’s well-being by opting for the PCD DNA test today. Protect your dog’s future with reliable genetic screening.
Ofkoarting: PCD-AM
Analysearre mutaasje: NME5 c.43delA
Erfskip: Autosomaal recessyf
Acronym
PCD-AM
Observearre frekwinsje
Klinyske earnst
Clinical klassifikaasje
Respiratory Diseases
Analysearre mutaasje
NME5 c.43delA
p.(T15Lfs*56)
p.(T15Lfs*56)
Mode fan erfskip
Autosomaal recessyf (Complete)
Test gearfetting:
Primary Ciliary Dyskinesia (PCD) is a genetic disorder affecting the cilia function in Alaskan Malamutes, leading to respiratory issues and reduced quality of life. A DNA test for PCD helps identify carriers and affected dogs, enabling responsible breeding decisions. Early detection through testing can prevent the spread of this condition within the breed. This test is crucial for maintaining the health and longevity of Alaskan Malamutes. Responsible breeders use DNA testing to promote healthier generations of dogs.
Beskikber út it pakket: Basic
Dizze DNA-test is opnommen fanôf ús pakket Basic - en is ek diel fan 'e pakketten Basic, Standard, Advanced, Complete.
Besjoch DNA-testpakketten →Kies it pakket dat it bêste past by jo fokken of sûnensstrategy fan jo bisten.
Understanding Primary Ciliary Dyskinesia (PCD) in Alaskan Malamutes
Primary Ciliary Dyskinesia (PCD) is a genetic disorder that affects the cilia, which are tiny hair-like structures that line the respiratory tract, making them crucial for clearing mucus and debris from the airways. This condition can lead to a variety of respiratory issues and chronic infections, significantly impacting the health and quality of life of affected dogs.
Genetic Basis of PCD
PCD is caused by mutations in genes that are essential for the proper functioning of cilia. In Alaskan Malamutes, specific genetic markers have been identified that are associated with this condition. Understanding the genetic basis of PCD helps in developing targeted management strategies and breeding programs aimed at reducing the prevalence of the disorder within the breed.
Clinical Signs of PCD
Dogs with PCD often exhibit a range of clinical signs, which can include chronic coughing, nasal discharge, and recurrent respiratory infections. These symptoms can manifest as early as puppyhood and may worsen over time if not properly managed. It is important for dog owners to recognize these signs and seek veterinary advice early on to ensure appropriate care and intervention.
Diagnosis of PCD
Diagnosis of Primary Ciliary Dyskinesia typically involves a combination of clinical evaluation, imaging studies, and genetic testing. The DNA test specifically designed for Alaskan Malamutes can identify the presence of mutations associated with PCD, providing clarity for breeders and owners regarding the risk of the condition in their dogs.
Management and Treatment
While there is no cure for PCD, effective management strategies can help improve the quality of life for affected dogs. These may include regular veterinary check-ups, medication to manage infections, and supportive care such as nebulization therapy to help clear mucus from the airways. Additionally, owners should be proactive in monitoring their dog's respiratory health and maintaining a clean living environment to reduce exposure to respiratory irritants.
Importance of DNA Testing
DNA testing for Primary Ciliary Dyskinesia is an essential tool for responsible breeding practices. By identifying carriers of the genetic mutations associated with PCD, breeders can make informed decisions to minimize the risk of passing the condition to future generations. This proactive approach is vital for maintaining the health and well-being of Alaskan Malamutes as a breed.
Ras erkend foar de test: Primêre siliêre dyskinesia yn Alaskan Malamute (PCD-AM)
- Alaskan Malamute
🧬 Interpretation of genotypes PCD-AM
Genotype
Status
🟡 N/N
Non-carrier - Gjin risiko
🟡 N/PCD-AM
Carrier - Gjin risiko
❌ PCD-AM/PCD-AM
Beynfloede - At Risk
FAQ: begripe de ynterpretaasje
Is in "Carrier" serieus?
Nee, it bist is oer it algemien sûn, mar kin de mutaasje oerjaan oan har neiteam.
Wat as in bist "oandwaande" is?
It draacht twa mutearre eksimplaren. Klinyske tekens wurde ferwachte ôfhinklik fan de sykte. It moat net fokt wurde.
Wêrom binne d'r ferskillen tusken manlik / froulik?
Guon sykten binne seks-keppele, sadat harren útdrukking fariearret ôfhinklik fan de bist syn seks.
Foarsizze Offspring
N/N (non-drager)
N/PCD-AM (Carrier)
PCD-AM/PCD-AM (Beynfloede)
DNA Test FAQ
Wat detektearret dizze DNA-test?
This DNA test detects the mutation associated with Primary Ciliary Dyskinesia In Alaskan Malamute (PCD-AM) in order to identify clear, carrier, or at-risk animals.
Wêrom testje in fokdier?
DNA-testen helpt fokkers om feiliger parings te plannen en it risiko te ferminderjen fan it oerdragen fan de mutaasje nei neiteam.
Wat is de erflike modus fan dizze test?
De erflike modus rapportearre foar dizze test is Autosomal Recessive.
Hokker mutaasje wurdt analysearre yn dizze test?
This test analyses the mutation NME5 c.43delA.
Is in dragerdier needsaaklik beynfloede?
Net needsaaklik. Ynterpretaasje hinget ôf fan it erflik patroan en de resultearjende genotyp.
References
Anderegg Linda, Im Hof Gut Michelle, Hetzel Udo, Howerth Elizabeth W, Leuthard Fabienne, Kyöstilä Kaisa, Lohi Hannes, Pettitt Louise, Mellersh Cathryn, Minor Katie M, Mickelson James R, Batcher Kevin, Bannasch Danika, Jagannathan Vidhya, Leeb Tosso. NME5 frameshift variant in Alaskan Malamutes with primary ciliary dyskinesia. PLoS Genet. 2019 Sep 3;15(9):e1008378. doi: 10.1371/journal.pgen.1008378. eCollection 2019 Sep.